| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-09 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-06 |